tag:blogger.com,1999:blog-6433463555544237674.post8255791998430363173..comments2023-10-03T03:27:09.961-07:00Comments on CATATAN APOTEKER: candesartanNH2http://www.blogger.com/profile/12408674621817062712noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-6433463555544237674.post-15145168263731353832013-12-23T17:21:06.765-08:002013-12-23T17:21:06.765-08:00to jonathan
daftar pustakanya
Anonim, 2008, Guidel...to jonathan<br />daftar pustakanya<br />Anonim, 2008, Guidelines and Protocol Chronic Kidney Disease-Identification,Evaluation and Management of Patients, British Columbia Medical Asociation<br /><br />Anonim. 2009. Pelayanan Informasi Obat. Jakarta: Departemen Kesehatan RI press. <br /><br />Aryanti, Y., 2009, Studi Penggunaan Obat Anti Hipertensi pada Pasien Penyakit Ginjal Kronik, Buletin Penelitian RSUD Dr Soetomo Vol 11, No2<br /><br />Depkes RI, 2006, Pedoman Pelayanan Farmasi (Tata Laksana Terapi Obat) untuk Pasien Geriatri, Departemen Kesehatan, Jakarta <br /><br />Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M., 2005, Pharmacotherapy, 6th ed., Appleton & Lange, USA.<br /><br /><br />Katzung, 2010. Farmakologi Dasar dan Klinik . Edisi 10. Jakarta : Penerbit Buku Kedokteran<br />Martindale. 2007. The Complete Drugs Reference. Ed. 36. London, Chicago: Parmaceutical Press.<br />Neal, M.J., 2002, At a Glance Farmakologi Medis edisi kelima, Erlangga Medical Series, Jakarta<br /><br />WHO Department of Noncommunicable Disease Surveillance Geneva. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO ConsultationPart 1: Diagnosis and Classification of Diabetes Mellitus . 1999<br /><br />Cernes, Mashavi,Zimlichman. 2011. Differential clinical profile of candesartan<br /> compared to other angiotensin receptor blockers. Dovepress<br />de Zeeuw D, Remuzzi G, Kirch W. 1997. Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment. J Hum Hypertens. 1997 Sep;11 Suppl 2:S37-42<br />Khawaja Z, Wilcox C. 2011. An overview of candesartan in clinical practice. Expert Rev Cardiovasc Ther. 2011 August ; 9(8): 975–982<br /><br />L. Lin, W. E. Phillips, and R. D. Manning Jr. 2009. Intrarenal angiotensin ii is associated with inflammation, renal damage and dysfunction in dahl salt-sensitive hypertension. J Am Soc Hypertens. 2009 September 1; 3(5): 306–314<br /><br />Okpechi I, Rayner B. 2010. Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction. Dovepress<br /><br /><br />Rosa M L D. 2010. Cardio classics revisited – focus on the role of candesartan. Dovepress<br /><br />Ramzi,Sophie,Roland. 2007. Effect of candesartan cilexetil on diabetic and non-diabetic hypertensive patients: meta-analysis of five randomized double-blind clinical trials. Dove Medical Press Limited<br /><br />Schmieder E, Martin S, Lang G, Bramlage P, Böhm M.2009. Review article: Angiotensin Blockade to Reduce Microvascular Damage in Diabetes Mellitus. Deutsches Ärzteblatt International⏐Dtsch Arztebl Int 2009; 106(34–35): 556–62<br />NH2https://www.blogger.com/profile/12408674621817062712noreply@blogger.comtag:blogger.com,1999:blog-6433463555544237674.post-90662202042962718072013-10-23T05:34:51.071-07:002013-10-23T05:34:51.071-07:00daftar pustakanya gak ada ya.. sumbernya dari mana...daftar pustakanya gak ada ya.. sumbernya dari manaAnonymoushttps://www.blogger.com/profile/03381620869743051501noreply@blogger.com